{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:55:59Z","timestamp":1790056559891,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejso.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.ejso.2016.12.009","type":"journal-article","created":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T08:16:39Z","timestamp":1483949799000},"page":"1088-1094","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Reduction of carcinomatosis risk using icodextrin as a carrier solution of intraperitoneal oxaliplatin chemotherapy"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2895-4140","authenticated-orcid":false,"given":"I.","family":"Jouvin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9053-6313","authenticated-orcid":false,"given":"H.","family":"Najah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Pimpie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Canet Jourdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Kaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mirshahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Eveno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4793-0008","authenticated-orcid":false,"given":"M.","family":"Pocard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ejso.2016.12.009_bib1","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/BF02050360","article-title":"Peritoneal seeding following potentially curative resection of colonic carcinoma: implications for adjuvant therapy","volume":"34","author":"Brodsky","year":"1991","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"10.1016\/j.ejso.2016.12.009_bib2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00384-014-2085-6","article-title":"Metachronous metastases from colorectal cancer: a population-based study in North-East Netherlands","volume":"30","author":"Elferink","year":"2015","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.ejso.2016.12.009_bib3","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1186\/s12885-015-1430-7","article-title":"Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial","volume":"15","author":"Klaver","year":"2015","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.ejso.2016.12.009_bib4","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/bjs.8679","article-title":"Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer","volume":"99","author":"Segelman","year":"2012","journal-title":"Br J Surg"},{"issue":"39","key":"10.1016\/j.ejso.2016.12.009_bib5","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.3748\/wjg.v18.i39.5489","article-title":"Peritoneal carcinomatosis of colorectal origin: incidence, prognosis and treatment options","volume":"18","author":"Klaver","year":"2012","journal-title":"World J Gastroenterol \u2013 WJG"},{"issue":"9","key":"10.1016\/j.ejso.2016.12.009_bib6","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","article-title":"8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer","volume":"15","author":"Verwaal","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2016.12.009_bib7","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","article-title":"Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin","volume":"27","author":"Elias","year":"2009","journal-title":"J\u00a0Clin Oncol \u2013 Off J Am Soc Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2016.12.009_bib8","first-page":"456","article-title":"Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy","volume":"36","author":"Elias","year":"2010","journal-title":"Eur J Surg Oncol\u00a0\u2013 J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2016.12.009_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1245\/s10434-012-2473-5","article-title":"Definition of patients presenting a high risk of developing peritoneal carcinomatosis after curative surgery for colorectal cancer: a systematic review","volume":"20","author":"Honor\u00e9","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2016.12.009_bib10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/SLA.0b013e31822638f6","article-title":"Results of systematic second-look surgery plus HIPEC in asymptomatic patients presenting a high risk of developing colorectal peritoneal carcinomatosis","volume":"254","author":"Elias","year":"2011","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.ejso.2016.12.009_bib11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrc2618","article-title":"Microenvironmental regulation of metastasis","volume":"9","author":"Joyce","year":"2009","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.ejso.2016.12.009_bib12","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/path.4281","article-title":"Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis","volume":"231","author":"Sandoval","year":"2013","journal-title":"J\u00a0Pathol"},{"issue":"9","key":"10.1016\/j.ejso.2016.12.009_bib13","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1681\/ASN.2010111197","article-title":"Blocking TGF-\u03b21 protects the peritoneal membrane from dialysate-induced damage","volume":"22","author":"Loureiro","year":"2011","journal-title":"J\u00a0Am Soc Nephrol \u2013 JASN"},{"issue":"4","key":"10.1016\/j.ejso.2016.12.009_bib14","doi-asserted-by":"crossref","first-page":"e4992","DOI":"10.1371\/journal.pone.0004992","article-title":"Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression","volume":"4","author":"Spaeth","year":"2009","journal-title":"PLoS One"},{"issue":"7162","key":"10.1016\/j.ejso.2016.12.009_bib15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature06188","article-title":"Mesenchymal stem cells within tumour stroma promote breast cancer metastasis","volume":"449","author":"Karnoub","year":"2007","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.ejso.2016.12.009_bib16","doi-asserted-by":"crossref","first-page":"e3894","DOI":"10.1371\/journal.pone.0003894","article-title":"Oncologic trogocytosis of an original stromal cells induces chemoresistance of ovarian tumours","volume":"3","author":"Rafii","year":"2008","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.ejso.2016.12.009_bib17","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/ijc.24886","article-title":"Hospicells (ascites-derived stromal cells) promote tumorigenicity and angiogenesis","volume":"126","author":"Pasquet","year":"2010","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.ejso.2016.12.009_bib18","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s11605-011-1736-y","article-title":"P.O.P.A. study: prevention of postoperative abdominal adhesions by icodextrin 4% solution after laparotomy for adhesive small bowel obstruction. A prospective randomized controlled trial","volume":"16","author":"Catena","year":"2012","journal-title":"J\u00a0Gastrointest Surg \u2013 Off J Soc Surg Aliment Tract"},{"issue":"8","key":"10.1016\/j.ejso.2016.12.009_bib19","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1093\/humrep\/der135","article-title":"Gynaecological endoscopic evaluation of 4% icodextrin solution: a European, multicentre, double-blind, randomized study of the efficacy and safety in the reduction of de novo adhesions after laparoscopic gynaecological surgery","volume":"26","author":"Trew","year":"2011","journal-title":"Hum Reprod Oxf Engl"},{"key":"10.1016\/j.ejso.2016.12.009_bib20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2482-13-34","article-title":"Influence of 4% icodextrin solution on peritoneal tissue response and adhesion formation","volume":"13","author":"Klink","year":"2013","journal-title":"BMC Surg"},{"issue":"5","key":"10.1016\/j.ejso.2016.12.009_bib21","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.surg.2013.04.054","article-title":"A\u00a0novel drug delivery system of intraperitoneal chemotherapy for peritoneal carcinomatosis using gelatin microspheres incorporating cisplatin","volume":"154","author":"Gunji","year":"2013","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2016.12.009_bib22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.colsurfb.2013.01.047","article-title":"Camptothecine encapsulated composite drug delivery system for colorectal peritoneal carcinomatosis therapy: biodegradable microsphere in thermosensitive hydrogel","volume":"106","author":"Liu","year":"2013","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"5","key":"10.1016\/j.ejso.2016.12.009_bib23","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00595-013-0674-6","article-title":"Intraperitoneal administration of cisplatin via an in situ cross-linkable hyaluronic acid-based hydrogel for peritoneal dissemination of gastric cancer","volume":"44","author":"Emoto","year":"2014","journal-title":"Surg Today"},{"key":"10.1016\/j.ejso.2016.12.009_bib24","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jinorgbio.2014.02.004","article-title":"A\u00a0cisplatin slow-release hydrogel drug delivery system based on a formulation of the macrocycle cucurbit[7]uril, gelatin and polyvinyl alcohol","volume":"134","author":"Oun","year":"2014","journal-title":"J\u00a0Inorg Biochem"},{"issue":"3","key":"10.1016\/j.ejso.2016.12.009_bib25","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jconrel.2011.12.001","article-title":"Hyaluronic acid-based hydrogel for regional delivery of paclitaxel to intraperitoneal tumors","volume":"158","author":"Bajaj","year":"2012","journal-title":"J\u00a0Control Release \u2013 Off J Control Release Soc"},{"key":"10.1016\/j.ejso.2016.12.009_bib26","first-page":"40","article-title":"Evaluation of the effects of hyaluronic acid-carboxymethyl cellulose barrier on ovarian tumor progression","volume":"7","author":"Picaud","year":"2014","journal-title":"J\u00a0Ovarian Res"},{"issue":"3","key":"10.1016\/j.ejso.2016.12.009_bib27","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.surg.2004.06.001","article-title":"Icodextrin reduces postoperative adhesion formation in rats without affecting peritoneal metastasis","volume":"137","author":"van den Tol","year":"2005","journal-title":"Surgery"},{"issue":"5","key":"10.1016\/j.ejso.2016.12.009_bib28","first-page":"318","article-title":"Icodextrin and Seprafilm do not interfere with colonic anastomosis in rats","volume":"39","author":"Baca","year":"2007","journal-title":"Eur Surg Res \u2013 Eur Chir Forsch Rech Chir Eur"},{"issue":"4","key":"10.1016\/j.ejso.2016.12.009_bib29","first-page":"324","article-title":"Effects of intraperitoneal 4% icodextrin solution on the healing of bowel anastomoses and laparotomy incisions in rabbits","volume":"5","author":"Rodgers","year":"2003","journal-title":"Colorectal Dis \u2013 Off J Assoc Coloproctol G B Irel"},{"issue":"12","key":"10.1016\/j.ejso.2016.12.009_bib30","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s00384-010-0952-3","article-title":"Biosutures improve healing of experimental weak colonic anastomoses","volume":"25","author":"Pascual","year":"2010","journal-title":"Int J Colorectal Dis"},{"issue":"4","key":"10.1016\/j.ejso.2016.12.009_bib31","doi-asserted-by":"crossref","first-page":"305","DOI":"10.5505\/tjtes.2013.98223","article-title":"Effects of abdominal adhesion-preventing 4% icodextrin solution on healing of bowel anastomoses","volume":"19","author":"Ko\u00e7","year":"2013","journal-title":"Ulus Travma Ve Acil Cerrahi Derg Turk J Trauma Emerg Surg TJTES"},{"issue":"9911","key":"10.1016\/j.ejso.2016.12.009_bib32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0140-6736(13)61687-6","article-title":"Benefits and harms of adhesion barriers for abdominal surgery: a systematic review and meta-analysis","volume":"383","author":"Broek","year":"2014","journal-title":"Lancet Lond Engl"},{"issue":"4","key":"10.1016\/j.ejso.2016.12.009_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/bjs.9395","article-title":"Risk factors for anastomotic leakage and leak-related mortality after colonic cancer surgery in a nationwide audit","volume":"101","author":"Bakker","year":"2014","journal-title":"Br J Surg"},{"issue":"10","key":"10.1016\/j.ejso.2016.12.009_bib34","first-page":"e661","article-title":"A\u00a0nationwide study on anastomotic leakage after colonic cancer surgery","volume":"14","author":"Krarup","year":"2012","journal-title":"Colorectal Dis \u2013 Off J Assoc Coloproctol G B Irel"},{"issue":"3","key":"10.1016\/j.ejso.2016.12.009_bib35","first-page":"254","article-title":"A\u00a0pilot study of adjuvant intraperitoneal 5-fluorouracil using 4% icodextrin as a novel carrier solution","volume":"29","author":"Hosie","year":"2003","journal-title":"Eur J Surg Oncol \u2013 J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2016.12.009_bib36","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/bjc.1994.392","article-title":"Pharmacokinetic study of 5-fluorouracil in a novel dialysate solution: a long-term intraperitoneal treatment approach for advanced colorectal carcinoma","volume":"70","author":"McArdle","year":"1994","journal-title":"Br J Cancer"},{"issue":"12","key":"10.1016\/j.ejso.2016.12.009_bib37","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/bjc.1996.672","article-title":"Prolonged intraperitoneal infusion of 5-fluorouracil using a novel carrier solution","volume":"74","author":"Kerr","year":"1996","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2016.12.009_bib38","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Intraperitoneal cisplatin and paclitaxel in ovarian cancer","volume":"354","author":"Armstrong","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ejso.2016.12.009_bib39","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1245\/s10434-014-4157-9","article-title":"Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study","volume":"22","author":"Spiliotis","year":"2015","journal-title":"Ann Surg Oncol"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798317300367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798317300367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T17:18:16Z","timestamp":1718990296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798317300367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0748798317300367"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2016.12.009","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduction of carcinomatosis risk using icodextrin as a carrier solution of intraperitoneal oxaliplatin chemotherapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology (EJSO)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2016.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}